Disclaimer: This product is intended for laboratory research use only. Not for human consumption.
PT-141 (Bremelanotide) is a synthetic peptide analogue of alpha-melanocyte-stimulating hormone ($\alpha$-MSH). In laboratory research, it is widely used to study the melanocortin system, neurobiology, and central nervous system regulation of melanocortin receptor signalling. This research-grade material enables investigation of receptor binding, signal transduction, and physiological responses mediated by melanocortin receptors (specifically MC3R and MC4R) under non-clinical, controlled conditions.
Key Features
-
Synthetic peptide suitable for in-vitro receptor binding and in-vivo animal model studies
-
Research-grade material for neurobiology and endocrinology research
-
Supplied as a lyophilised solid for enhanced stability
-
Supplied at 10 mg for research purposes
-
Each batch released only after stringent quality checks
Handling and Storage
After reconstitution (mixed with bacteriostatic sterile water):
-
Store in a refrigerator (2–8°C).
-
Do not freeze once reconstituted.
-
Use within 30–45 days for optimal stability.
About PT-141 in Research
PT-141 acts as a non-selective agonist of melanocortin receptors, playing a significant role in the regulation of melanocortin-mediated receptor activation through central nervous system pathways. In laboratory settings, it is used to probe the mechanisms of melanocortin-mediated dysfunction, explore the role of melanocortin signaling in energy homeostasis, and investigate potential research applications involving MC4 receptor-mediated pathways.
Who Should Use?
This product is strictly intended for use by:
Synthesis & Quality
Manufactured via validated, controlled peptide synthesis processes to ensure high purity and lot-to-lot consistency. Each batch undergoes identity, purity (HPLC/MS), and appearance verification prior to release.
Legal & Safety
For laboratory research only. Not intended for human or veterinary use. Products are not medicines, supplements, foods, or cosmetics.